Ruane Clinical Research Group, Inc. ( Site 5624) — Los Angeles, California

Ruane Clinical Research Group, Inc. ( Site 5624) is a clinical research site located in Los Angeles, California, United States 90036.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Ruane Clinical Research Group, Inc. ( Site 5624) has participated in 1 clinical trials.

Therapeutic areas: HIV-1 Infection.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ruane Clinical Research Group, Inc. ( Site 5624)?

Ruane Clinical Research Group, Inc. ( Site 5624) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ruane Clinical Research Group, Inc. ( Site 5624) conducted?

Ruane Clinical Research Group, Inc. ( Site 5624) has 1 clinical trials on record. Their work covers HIV-1 Infection.

Is Ruane Clinical Research Group, Inc. ( Site 5624) accredited by Crixeo Health?

Ruane Clinical Research Group, Inc. ( Site 5624) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ruane Clinical Research Group, Inc. ( Site 5624)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.